Adenosine modulates cell proliferation in human colonic adenocarcinoma. I. Possible involvement of adenosine A1 receptor subtypes in HT29 cells

European Journal of Pharmacology
V LelièvreJ Falcòn

Abstract

Several lines of evidence suggest that extracellular adenosine interacting with specific cell surface receptors may influence cell growth and differentiation of cancer cells in culture. The data presented here demonstrate that various treatments of human colonic adenocarcinoma HT29 cells in the presence of exogenously added adenosine deaminase, which converts extracellular adenosine into inosine, resulted in a significant decrease of the proliferation. Cell growth inhibition was also observed in the presence of adenosine A1 receptor antagonists. These various treatments also induced a significant elevation of basal intracellular cAMP levels. This strongly indicated that extracellular adenosine was maintaining low intracellular cAMP levels in HT29 cells. A partial pharmacological characterization of the binding of the adenosine A1 receptor agonist [3H]CCPA (2-chloro-N6-cyclopentyl[2,3,4,5-(3)H]adenosine), and the adenosine A1 receptor antagonist [3H]DPCPX (cyclopentyl-1,3-dipropyl[2,3-(3)H]xanthine), to HT29 cells is also provided. Together the data support the idea that A1-adenosine receptors are expressed in HT29 cells and might mediate part of the above described effects of adenosine on cell proliferation.

References

Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·Q Y ZhouO Civelli
Sep 30, 1992·Biochemical and Biophysical Research Communications·H B TeyC H Tan
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N R RodriguesD P Lane
Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Apr 27, 1988·European Journal of Pharmacology·A Reymann, A Gniess
Jun 1, 1988·Naunyn-Schmiedeberg's Archives of Pharmacology·M J LohseM Grifantini
Jan 1, 1987·Naunyn-Schmiedeberg's Archives of Pharmacology·R F BrunsC C Huang
Mar 1, 1971·Proceedings of the Society for Experimental Biology and Medicine·J FoghL Ramos
Aug 4, 1993·Journal of the National Cancer Institute·E R Greenberg, J A Baron
Apr 1, 1996·British Journal of Pharmacology·F R CohenN J Birdsall

❮ Previous
Next ❯

Citations

Mar 29, 2001·BioFactors·R A MittalH E Khoo
Oct 2, 2001·The Journal of Comparative Neurology·F L ChristofiH J Cooke
Jun 26, 2013·Purinergic Signalling·Geoffrey Burnstock, Francesco Di Virgilio
Sep 29, 2000·Pharmacology & Therapeutics·J Spychala
Feb 24, 2001·Breast Cancer Research and Treatment·T A Slotkin, F J Seidler
Jan 17, 2014·Cardiovascular Drugs and Therapy·Ryszard T SmolenskiPaul J R Barton
Sep 21, 2007·Cancer Investigation·Denisa StreitováVladimír Znojil
May 29, 2001·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Z Zhao, S A Rivkees
Mar 10, 2007·Journal of Cellular Physiology·Stefania GessiPier Andrea Borea
Dec 24, 2002·Prostate Cancer and Prostatic Diseases·M D SlaterJ A Barden
Apr 3, 2007·Neurochemical Research·Carlos Alberto CastilloMairena Martín
Apr 29, 2021·Signal Transduction and Targeted Therapy·Zhao HuangYong Tang
Oct 29, 1998·Biochemical and Biophysical Research Communications·M HöpfnerH Scherübl
Jul 24, 2007·Biochimica Et Biophysica Acta·Elizandra BraganholAna M O Battastini

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.